EP0462111A4 - Homing sequences and their uses - Google Patents
Homing sequences and their usesInfo
- Publication number
- EP0462111A4 EP0462111A4 EP19900902104 EP90902104A EP0462111A4 EP 0462111 A4 EP0462111 A4 EP 0462111A4 EP 19900902104 EP19900902104 EP 19900902104 EP 90902104 A EP90902104 A EP 90902104A EP 0462111 A4 EP0462111 A4 EP 0462111A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- homing sequences
- homing
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28920188A | 1988-12-23 | 1988-12-23 | |
US289201 | 1988-12-23 | ||
US31573689A | 1989-02-24 | 1989-02-24 | |
US315736 | 1989-02-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0462111A1 EP0462111A1 (fr) | 1991-12-27 |
EP0462111A4 true EP0462111A4 (en) | 1992-07-08 |
Family
ID=26965504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19900902104 Withdrawn EP0462111A4 (en) | 1988-12-23 | 1989-11-10 | Homing sequences and their uses |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0462111A4 (fr) |
JP (1) | JPH04504501A (fr) |
WO (1) | WO1990007321A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776775A (en) * | 1989-02-21 | 1998-07-07 | Dana-Farber Cancer Institute | Anti-LAM 1-3 antibody and hybridoma |
US7238668B1 (en) | 1989-09-01 | 2007-07-03 | Fred Hutchinson Cancer Research Center | Inhibition of lymphocyte adherence with CS-1-peptides and fragments thereof |
US7750137B2 (en) | 1995-09-01 | 2010-07-06 | Millennium Pharmaceuticals, Inc. | Mucosal vascular addressins |
US7803904B2 (en) | 1995-09-01 | 2010-09-28 | Millennium Pharmaceuticals, Inc. | Mucosal vascular addressing and uses thereof |
US6551593B1 (en) | 1995-02-10 | 2003-04-22 | Millennium Pharmaceuticals, Inc. | Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
US6111090A (en) * | 1996-08-16 | 2000-08-29 | Schering Corporation | Mammalian cell surface antigens; related reagents |
CN103212071B (zh) * | 2005-08-25 | 2017-12-12 | 亚利桑那大学董事会 | 干细胞融合癌发生模型 |
UA116189C2 (uk) | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
PE20141672A1 (es) | 2011-05-02 | 2014-11-26 | Millennium Pharm Inc | FORMULACION PARA ANTICUERPO ANTI-alfa4�7 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0303463A2 (fr) * | 1987-08-11 | 1989-02-15 | The Board Of Trustees Of The Leland Stanford Junior University | Méthode pour contrôler l'extravasation des leucocytes |
-
1989
- 1989-11-10 WO PCT/US1989/005067 patent/WO1990007321A2/fr active Search and Examination
- 1989-11-10 JP JP2502783A patent/JPH04504501A/ja active Pending
- 1989-11-10 EP EP19900902104 patent/EP0462111A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0303463A2 (fr) * | 1987-08-11 | 1989-02-15 | The Board Of Trustees Of The Leland Stanford Junior University | Méthode pour contrôler l'extravasation des leucocytes |
Non-Patent Citations (1)
Title |
---|
See also references of WO9007321A3 * |
Also Published As
Publication number | Publication date |
---|---|
JPH04504501A (ja) | 1992-08-13 |
WO1990007321A2 (fr) | 1990-07-12 |
WO1990007321A3 (fr) | 2010-05-27 |
EP0462111A1 (fr) | 1991-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8919556D0 (en) | Periscope | |
GB2210043B (en) | Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides | |
GB2218786B (en) | Arrow gun | |
EP0413084A3 (en) | Projectile | |
EP0462111A4 (en) | Homing sequences and their uses | |
GB2284251B (en) | Projectile | |
GB8914067D0 (en) | Projectile | |
GB8918252D0 (en) | Armour | |
ZW10789A1 (en) | Primer | |
YU2589A (en) | Improved hide | |
GB2313435A8 (en) | Field howitzers | |
GB2222511B (en) | Body armour | |
IL89599A0 (en) | Armor | |
GB8817747D0 (en) | Firearms | |
GB2215014B (en) | Short range projectile | |
GB8819841D0 (en) | Shooting facility | |
GB8914921D0 (en) | Projectile | |
ZA898616B (en) | Primer | |
BG47144A1 (en) | Experimental projectile | |
GB8805539D0 (en) | Missiles | |
GB8814439D0 (en) | Weapons | |
ZA90343B (en) | Weapon | |
GB8819965D0 (en) | Improved projectile | |
ZA893162B (en) | Environmental chamber and construction thereof | |
IE882564L (en) | Pyridobenzoxazines and pyridobenzothiazines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19910627 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): CH DE FR GB LI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19920521 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): CH DE FR GB LI |
|
17Q | First examination report despatched |
Effective date: 19931125 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19960103 |